#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14650	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2100	692.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1691	1691	T	825	T,C	747,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14650	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2100	692.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1425	1425	C	890	C	831	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14650	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2100	692.9	0	HET	.	.	.	A1526C,G	.	1526	1526	A	1767	1767	A	676	A,C,G	476,131,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27228	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3666	741.4	0	.	n	.	0	T695C	SNP	695	695	T	1072	1072	C	856	C,T	794,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27228	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3666	741.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	2015	2015	G	919	G,T	847,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27228	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3666	741.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2348	2348	C	870	C,A	810,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27228	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3666	741.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2422	2422	A	874	A	818	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27228	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3666	741.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2974	2974	C	982	C	917	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	1934	folP	852	852	100.0	folP.l15.c4.ctg.1	1580	122.1	1	SNP	p	R228S	0	.	.	682	684	CGC	1069	1071	CGC	194;194;194	C;G;C	183;181;177	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4876	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3488	139.4	1	SNP	p	S91F	0	.	.	271	273	TCC	623	625	TCC	163;165;163	T;C;C	147;152;149	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4876	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3488	139.4	1	SNP	p	D95N	0	.	.	283	285	GAC	635	637	GAC	166;169;169	G;A;C	155;156;157	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4876	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3488	139.4	1	SNP	p	D95G	0	.	.	283	285	GAC	635	637	GAC	166;169;169	G;A;C	155;156;157	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1588	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1345	117.7	1	SNP	p	G45D	1	.	.	133	135	GAC	520	522	GAC	220;223;224	G;A;C,A	209;207;211,1	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	832	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c17.ctg.1	993	83.2	0	.	n	.	0	T10C	SNP	10	10	T	348	348	C	186	C,T	172,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	832	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c17.ctg.1	993	83.2	0	.	n	.	0	A197.	DEL	197	197	A	534	534	A	182	A	177	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4470	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3089	144.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1749	1751	GCA	211;210;210	G,A;C,T;A,G	189,1;184,1;181,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4470	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3089	144.5	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2232	2234	ATT	162;161;161	A;T;T	145;145;148	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4470	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3089	144.5	1	SNP	p	D86N	0	.	.	256	258	GAC	702	704	GAC	168;170;170	G;A;C	158;161;160	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4470	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3089	144.5	1	SNP	p	S87R	0	.	.	259	261	AGT	705	707	AGT	168;169;168	A,C;G;T	155,1;158;152	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4470	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3089	144.5	1	SNP	p	S87I	0	.	.	259	261	AGT	705	707	AGT	168;169;168	A,C;G;T	155,1;158;152	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4470	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3089	144.5	1	SNP	p	S87W	0	.	.	259	261	AGT	705	707	AGT	168;169;168	A,C;G;T	155,1;158;152	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4470	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3089	144.5	1	SNP	p	S88P	0	.	.	262	264	TCC	708	710	TCC	169;173;173	T;C;C	156;161;161	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4070	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2578	157.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1495	1497	GGC	201;200;192	G;G;C	189;186;178	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2486	185.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1307	1309	GCA	247;251;253	G;C;A	226;233;236	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2486	185.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1310	1312	ATC	253;254;254	A;T;C	237;238;234	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2486	185.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1322	1324	GTG	248;247;247	G;T;G	231;228;230	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2486	185.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1322	1324	GTG	248;247;247	G;T;G	231;228;230	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2486	185.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1826	1828	ACC	216;217;219	A;C;C,A	196;199;198,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2486	185.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1880	1882	GCG	211;213;210	G;C;G	188;170;179	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2486	185.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1880	1882	GCG	211;213;210	G;C;G	188;170;179	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2486	185.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2003	2005	GGT	209;209;209	G,T;G;T	192,1;189;186	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2486	185.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2012	2014	GGC	213;214;213	G;G;C	190;189;186	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2486	185.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2030	2032	CCG	198;200;204	C,G;C;G	140,1;172;166	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	120	99.17	penA.l15.c4.ctg.2	120	0.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	39	41	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	120	99.17	penA.l15.c4.ctg.2	120	0.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	48	50	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	15	4620	penA	1752	120	99.17	penA.l15.c4.ctg.2	120	0.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	66	68	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5732	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3077	185.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1618	1620	CCG	202;201;199	C;C;G	178;180;173	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1966	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1808	108.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	400	402	GGC	138;138;140	G;G;C	128;128;128	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1966	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1808	108.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	582	582	C	139	C	130	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3048	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	1454	208.4	0	.	p	.	0	G120D	NONSYN	358	360	GGC	622	624	GAC	252;253;254	G;A;C	234;234;237	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3048	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	1454	208.4	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	625	627	AAC	252;255;258	A;A;C	237;238;240	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11628	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4895	237.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1969	1971	CAT	246;249;251	C;A;T	234;234;238	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1272	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	902	139.8	1	SNP	p	V57M	0	.	.	169	171	GTG	446	448	GTG	262;261;259	G;T;G,T	246;244;241,1	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
